UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - solid+tumors
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Engineered T Cells Capable of Simultaneous Tumor Targeting and Alteration of Tumor Microenvironment Through Vasculature Normalization (UCLA Case No. 2023-264)
UCLA researchers in the Department of Microbiology, Immunology and Molecular Genetics have built a series of chimeric antigen receptor (CAR)-T cells that target different antigens and secrete different anti-angiogenic proteins. Additionally, researchers also constructed bispecific CARs that respond to tumor antigen and pro-angiogenic molecules. BACKGROUND:...
Published: 6/27/2024
|
Inventor(s):
Yvonne Chen
Keywords(s):
Cancer
,
Cancer Immunotherapy
,
CAR-T cell therapy
,
immunosuppression
,
Immunosuppressive Drug
,
Immunotherapy
,
solid tumors
,
Tumor microenvironment
,
tumor vasculature
,
VEGF
Category(s):
Therapeutics > Oncology
Targeting Serotonin Transporter (SERT) for Cancer Immunotherapy (UCLA Case No. 2024-204)
UCLA researchers in the Department of Microbiology Immunology and Molecular Genetics have unveiled a novel therapeutic strategy utilizing SSRIs for solid cancer immunotherapy. BACKGROUND: Immunotherapy has become a highly effective method to combat cancer that enhances a patient’s immune system to attack tumors with high specificity. For instance,...
Published: 6/18/2024
|
Inventor(s):
Lili Yang
Keywords(s):
Cancer
,
Immune checkpoint blockade
,
immune checkpoint inhibitors
,
Immunotherapy
,
selective serotonin reuptake inhibitors (SSRIs)
,
serotonin
,
solid tumors
,
T Cell
Category(s):
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy